Across TCGA pan-cancer cohorts, EEF1DP6 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of EEF1DP6’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where EEF1DP6 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EEF1DP6 is over-expressed in tumor.

KIRC and LIHC are the cancer types where EEF1DP6 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EEF1DP6 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	IV	+0.128	.011	2	view →
LIHC	Male	All	+0.026	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: EEF1DP6 RNA expression & survival · all EEF1DP6 data types